What are the symptoms of diffuse lung cancer

As we all know, lung cancer is one of the most common malignant tumors in clinical practice. Clinically, early detection, early diagnosis and early treatment of this disease are the key to ensuring that patients prolong their life and improve their quality of life. So what are the common symptoms of diffuse lung cancer? What is the best way to treat diffuse lung cancer clinically?

1. The morphology of diffuse lung cancer is mostly round or quasi-round nodules or masses, but some diffuse lung cancers can also be patchy or irregular in shape, and satellite lesions can be seen in a few.

2. The internal manifestation of diffuse lung cancer is that the tumor density is relatively uniform, while the density of some parts is uneven. Bubble sign, bronchial inflation sign and honeycomb changes can be seen. Pathologically, it is the lung structure not affected by the tumor, the cross section of small bronchi or bronchioles, and the air cavity between the spinous processes.

3. The edges are mostly irregular, uneven, and have lobulation signs, mostly deep lobulation. This is because the resistance of different parts of the tumor is different during the development of the tumor, and the growth rate is uneven. The main pathological basis for the lobulation of diffuse lung cancer is the fibrous hyperplasia between the lobules. Sawtooth signs, small thorn-like protrusions and fine burrs can be seen. The burrs of diffuse lung cancer are mostly thin and short, dense, radial, and slightly thicker near the tumor.

CLS biological therapy can help clear residual cancer cells in the patient's body, restore the patient's immune function to identify and kill cancer cells, thereby preventing and controlling the recurrence and metastasis of tumor cells, regulating and enhancing the patient's immune function, improving the autonomous anti-cancer immune ability, better preventing the late spread of cardiac cancer, improving the patient's prognosis, prolonging the patient's effective survival, and reducing the mortality rate of late cardiac cancer. After surgery, tumor patients can use CLS biological therapy to clear scattered tumor cells in the body and prevent the recurrence and metastasis of various cardiac cancers; combined with radiotherapy and chemotherapy, it can reduce the toxic side effects of radiotherapy and chemotherapy and improve the efficacy of radiotherapy and chemotherapy; tumor patients in the recovery period use biological therapy for consolidation treatment, which can control tumor cell metastasis and recurrence, enhance immunity, and improve the patient's quality of life and increase the patient's survival.